Frank Ruffo

Track

Insider profile

Currently holds a position at Aclaris Therapeutics Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-Founder, Chief Financial Officer Aclaris Therapeutics Inc Dec. 31, 2016 -
Co-Founder, Chief Financial Officer, Secretary Aclaris Therapeutics Inc July 1, 2012 - Dec. 31, 2016
Frank Ruffo's trades of Aclaris Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-14 2022-03-10
S Sale
32,084 +43.5%
339.52
US$1,337,135 		32,084 +43.5% 339.52 US$1,337,135
2022-02-11 2022-02-09
S Sale
24,585 -11.7%
53.74
US$3,246,798 		24,585 -11.7% 53.74 US$3,246,798
2021-06-02 2021-06-02
S Sale
22,430 -45.9%
63.84
US$2,933,911 		22,430 -45.9% 63.84 US$2,933,911
2021-06-02 2021-06-02
S Sale
12,587 -6.8%
21.51
US$270,748 		12,587 -6.8% 21.51 US$270,748
2021-04-26 2021-04-26
PlS Planned sale
100 -0.1%
26.44
US$2,644 		100 -0.1% 26.44 US$2,644
2021-04-26 2021-04-26
PlS Planned sale
27,239 -15.2%
25.79
US$702,584 		27,239 -15.2% 25.79 US$702,584
2021-04-26 2021-04-23
PlS Planned sale
800 -0.4%
27.33
US$21,863 		800 -0.4% 27.33 US$21,863
2021-04-26 2021-04-23
PlS Planned sale
29,200 -14.0%
26.64
US$777,797 		29,200 -14.0% 26.64 US$777,797
2021-04-26 2021-04-22
PlS Planned sale
30,000 -12.5%
26.84
US$805,218 		30,000 -12.5% 26.84 US$805,218